nach oben

Clinical and Translational Oncology

Erschienen in:

24.05.2020 | Review Article

The new function of circRNA: translation

verfasst von: Y. Shi, X. Jia, J. Xu

Erschienen in: Clinical and Translational Oncology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Circular RNAs (circRNAs) have been considered a special class of non-coding RNAs without 5′ caps and 3′ tails which are covalently closed RNA molecules generated by back splicing of mRNA. For a long time, circRNAs have been considered to be directly involved in various biological processes as functional RNA. In recent years, a variety of circRNAs have been found to have translational functions, and the resultant peptides also play biological roles in the emergence and progression of human disease. The discovery of these circRNAs and their encoded peptides has enriched genomics, helped us to study the causes of diseases, and promoted the development of biotechnology. The purpose of this review is to summarize the research progress of the detection methods, translation initiation mechanism, as well as functional mechanism of peptides encoded by circRNAs, with the goal of providing the directions for the discovery of biomarkers for diagnosis, prognosis, and therapeutic targets for human disease.

Pamudurti NR, Bartok O, Jens M, et al. Translation of CircRNAs. Mol Cell. 2017;66:9–21.PubMedPubMedCentral

Chekulaeva M Rajewsky N. Roles of long noncoding RNAs and circular RNAs in Translation. Cold Spring Harb Perspect Biol. 2019;11:a032680.PubMedPubMedCentral

Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA. 1976;73:3852–6.PubMedPubMedCentral

Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141–57.PubMedPubMedCentral

Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176:869–81.PubMedPubMedCentral

Zhang Y, Zhang XO, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51:792–806.PubMed

Zganiacz D, Milanowski R. Characteristics of circular ribonucleic acid molecules (circRNA). Postepy Biochem. 2017;63:221–32.PubMed

Chen N, Zhao G, Yan X, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19:218.PubMedPubMedCentral

Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256–64.PubMed

10.

Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333–8.PubMed

11.

Conn VM, Hugouvieux V, Nayak A, et al. A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation. Nat Plants. 2017;3:17053.PubMed

12.

Fu L, Chen Q, Yao T, et al. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma. Oncotarget. 2017;8:43878–88.PubMedPubMedCentral

13.

Chen L, Zhang S, Wu J, et al. CircRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 2017;36:4551–61.PubMedPubMedCentral

14.

Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66:1151–64.PubMed

15.

Du WW, Yang W, Liu E, et al. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44:2846–58.PubMedPubMedCentral

16.

Du WW, Fang L, Yang W, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24:357–70.PubMed

17.

Bi W, Huang J, Nie C, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway. J Exp Clin Cancer Res. 2018;37:275.PubMedPubMedCentral

18.

Chang CY, Sarnow P. Initiation of protein synthesis by the eukaryotic. Transl Appar Circ RNAs Sci. 1995;268:415–7.

19.

Xia X, Li X, Li F, et al. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1. Mol Cancer. 2019;18:131.PubMedPubMedCentral

20.

Zheng X, Chen L, Zhou Y, et al. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer. 2019;18:47.PubMedPubMedCentral

21.

Zhang M, Huang N, Yang X, et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene. 2019;37:1805–14.

22.

Yang Y, Gao X, Zhang M, et al. Novel role of FBXW7 circular RNA in Repressing glioma tumorigenesis. J Natl Cancer Inst. 2018;110:304–15.

23.

Zhang M, Zhao K, Xu X, et al. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 2018;9:4475.PubMedPubMedCentral

24.

Legnini L, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22–37.PubMedPubMedCentral

25.

Zhao J, Lee EE, Kim J, et al. Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus. Nat Commun. 2019;10:2300.PubMedPubMedCentral

26.

Liang WC, Wong CW, Liang PP, et al. Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 2019;20:84.PubMedPubMedCentral

27.

Banko JL, Klann E. Cap-dependent translation initiation and memory. Prog Brain Res. 2008;169:59–80.PubMed

28.

Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell. 2009;136:731–45.PubMedPubMedCentral

29.

Merrick WC. Cap-dependent and cap-independent translation in eukaryotic systems. Gene. 2004;332:1–11.PubMed

30.

Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 2017;27:626–41.PubMedPubMedCentral

31.

Gu C, Zhou N, Wang Z, et al. CircGprc5a promoted bladder oncogenesis and metastasis through Gprc5a-targeting peptide. Mol Ther Nucleic Acids. 2018;13:633–41.PubMedPubMedCentral

32.

Zhi X, Zhang J, Cheng Z, et al. CircLgr4 drives colorectal tumorigenesis and invasion through Lgr4-targeting peptide. Int J Cancer. 2019. https://doi.org/10.1002/ijc.32549.CrossRefPubMed

33.

Imataka H, Olsen HS, Sonenberg N. A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J. 1997;16:817–25.PubMedPubMedCentral

34.

Morino S, Imataka H, Svitkin YV, et al. Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap- dependent translation, and the C-terminal one-third functions as a modulatory region. Mol Cell Biol. 2000;20:468–77.PubMedPubMedCentral

35.

Liberman N, Gandin V, Svitkin YV, et al. DAP5 associates with eIF2β and eIF4AI to promote internal ribosome entry site driven translation. Nucleic Acids Res. 2015;43:3764–75.PubMedPubMedCentral

36.

Lamphear BJ, Kirchweger R, Skern T, et al. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem. 1995;270:21975–83.PubMed

37.

Hellen CU, Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 2001;15:1593–612.PubMed

38.

Kearse MG, Wilusz JE. Non-AUG translation: a new start for protein synthesis in eukaryotes. Genes Dev. 2017;31:1717–31.PubMedPubMedCentral

39.

Abe N, Hiroshima M, Maruyama H, et al. Rolling circle amplification in a prokaryotic translation system using small circular RNA. Angew Chem Int Ed Engl. 2013;52:7004–8.PubMed

40.

Abe N, Matsumoto K, Nishihara M, et al. Rolling circle translation of circular RNA in living human cells. Sci Rep. 2015;5:16435.PubMedPubMedCentral

41.

Warner JR, Knopf PM, Rich A. A multiple ribosomal structure in protein synthesis. Proc Natl Acad Sci USA. 1963;49:122–9.PubMedPubMedCentral

42.

Chassé H, Boulben S, Costache V, et al. Analysis of translation using polysome profiling. Nucleic Acids Res. 2017;45:e15.PubMed

43.

Ingolia NT, Ghaemmaghami S, Newman JR, et al. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218–23.PubMedPubMedCentral

44.

Ingolia NT, Brar GA, Rouskin S, et al. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat Protoc. 2012;7:1534–50.PubMedPubMedCentral

45.

Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34–42.PubMed

46.

Wang J, Gribskov M. IRESpy: an XGBoost model for prediction of internal ribosome entry sites. BMC Bioinformatics. 2019;20:409.PubMedPubMedCentral

47.

Zhao J, Wu J, Xu T, et al. IRESfinder: identifying RNA internal ribosome entry site in eukaryotic cell using framed K-mer features. J Genet Genomics. 2018;45:403–6.PubMed

48.

Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m⁶A RNA methylomes revealed by m⁶A-seq. Nature. 2012;485:201–6.PubMed

49.

Molinie B, Giallourakis CC. Genome-wide location analyses of N6-methyladenosine modifications (m⁶A-Seq). Methods Mol Biol. 2017;1562:45–53.PubMedPubMedCentral

50.

Plaza S, Menschaert G, Payre F. In search of lost small peptides. Annu Rev Cell Dev Biol. 2017;33:391–416.PubMed

51.

Meng X, Chen Q, Zhang P, et al. CircPro: an integrated tool for the identification of circRNAs with protein-coding potential. Bioinformatics. 2017;33:3314–6.PubMed

52.

Sun P, Li G. CircCode: a powerful tool for identifying circRNA coding ability. Front Genet. 2019;10:981.PubMedPubMedCentral

53.

Spriggs KA, Stoneley M, Bushell M, et al. Reprogramming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell. 2008;100:27–38.PubMed

54.

Wang Y, Wang Z. Efficient backsplicing produces translatable circular mRNAs. RNA. 2015;21:172–9.PubMedPubMedCentral

55.

Mo D, Li X, Raabe CA, et al. A universal approach to investigate circRNA protein coding function. Sci Rep. 2019;9:11684.PubMedPubMedCentral

Titel: The new function of circRNA: translation
verfasst von: Y. Shi
X. Jia
J. Xu
Publikationsdatum: 24.05.2020
Verlag: Springer International Publishing
Erschienen in: Clinical and Translational Oncology / Ausgabe 12/2020
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-020-02371-1

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The new function of circRNA: translation

Abstract

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

A population perspective on the use of external beam radiotherapy in Catalonia, Spain

Potential biomarkers for early detection of pancreatic ductal adenocarcinoma

Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy

Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid

Tumor microenvironment, immune response and post-radiotherapy tumor clearance

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie